NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Open in Screener

CDNA

Caredx Inc

May 09 • 01:48PM ET

15.49

Dollar change +0.10
Percentage change 0.65	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: NTRA ILMN FLGT GH EXAS TWST VRTX CRSP TXG QGEN

| Held by: ARKG VTI IWM XBI VXF VB VBK IWN PBE IBB

Index	RUT	P/E	13.44	EPS (ttm)	1.15	Insider Own	6.92%	Shs Outstand	55.46M	Perf Week	3.27%
Market Cap	862.49M	Forward P/E	93.88	EPS next Y	0.17	Insider Trans	-1.81%	Shs Float	51.82M	Perf Month	-18.69%
Income	68.54M	PEG	-	EPS next Q	-0.10	Inst Own	101.45%	Short Float	11.68%	Perf Quarter	-30.88%
Sales	346.42M	P/S	2.49	EPS this Y	-137.81%	Inst Trans	4.02%	Short Ratio	6.43	Perf Half Y	-32.36%
Book/sh	6.84	P/B	2.26	EPS next Y	146.92%	ROA	14.55%	Short Interest	6.05M	Perf Year	47.81%
Cash/sh	4.15	P/C	3.74	EPS next 5Y	-11.41%	ROE	21.57%	52W Range	9.99 - 34.84	Perf YTD	-27.65%
Dividend Est.	-	P/FCF	42.80	EPS past 5Y	-	ROI	16.99%	52W High	-55.54%	Beta	2.22
Dividend TTM	-	Quick Ratio	3.84	Sales past 5Y	24.04%	Gross Margin	66.92%	52W Low	55.06%	ATR (14)	1.13
Dividend Ex-Date	-	Current Ratio	4.11	EPS Y/Y TTM	136.76%	Oper. Margin	-8.91%	RSI (14)	39.66	Volatility	6.27% 6.57%
Employees	650	Debt/Eq	0.08	Sales Y/Y TTM	25.92%	Profit Margin	19.79%	Recom	1.89	Target Price	28.62
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	41.89%	Payout	0.00%	Rel Volume	1.26	Prev Close	15.39
Sales Surprise	0.40%	EPS Surprise	8.08%	Sales Q/Q	17.54%	Earnings	Apr 30 AMC	Avg Volume	941.76K	Price	15.49
SMA20	-9.03%	SMA50	-14.29%	SMA200	-33.53%	Trades		Volume	807,275	Change	0.65%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-15-25	Upgrade	Wells Fargo	Underweight → Equal Weight	$28 → $24
Aug-28-24	Initiated	Wells Fargo	Underweight	$28
Aug-19-24	Upgrade	BTIG Research	Neutral → Buy	$40
May-13-24	Downgrade	Raymond James	Outperform → Mkt Perform
May-01-24	Upgrade	Craig Hallum	Hold → Buy	$15
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight	$10
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform	$12
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight	$19 → $9
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold	$26 → $9
Apr-25-22	Initiated	Stephens	Overweight	$50
Jul-20-21	Resumed	BTIG Research	Buy	$115
Jun-03-21	Initiated	Goldman	Buy	$95
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy	$47 → $55
Oct-08-20	Reiterated	H.C. Wainwright	Buy	$45 → $47
Oct-02-20	Reiterated	H.C. Wainwright	Buy	$40 → $45
Aug-05-20	Reiterated	H.C. Wainwright	Buy	$37 → $40
Jun-26-20	Initiated	BTIG Research	Buy	$40

Show Previous Ratings

May-01-25 03:17AM	CareDx Inc (CDNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments (GuruFocus.com) -10.72%
Apr-30-25 08:39PM	CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript (Seeking Alpha) -6.89%
05:50PM	CareDx (CDNA) Tops Q1 Earnings Estimates (Zacks)
04:50PM	CareDx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports First Quarter 2025 Results (Business Wire)
07:05AM	Loading…
Apr-29-25 07:05AM	CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-24-25 07:05AM	CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-21-25 04:01PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-08-25 07:05AM	CareDx to Report First Quarter 2025 Financial Results (Business Wire)
Apr-04-25 12:40PM	Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock? (Zacks)
Mar-11-25 07:05AM	CareDx Launches Two Expanded Indications for AlloSure Testing Services (Business Wire)
Feb-27-25 02:20AM	CareDx Inc (CDNA) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-26-25 07:00PM	CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:56PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
10:39AM	Loading…
Feb-25-25 10:39AM	CareDx Inc (CDNA) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
07:05AM	CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict (Business Wire)
Feb-20-25 07:05AM	CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients (Business Wire) -5.34%
Feb-13-25 07:05AM	CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies (Business Wire)
Feb-11-25 07:05AM	CareDx to Report Fourth Quarter and Full Year 2024 Financial Results (Business Wire) -8.43%
03:22AM	CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock? (Zacks)
Feb-10-25 02:51PM	Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj (CNBC TV) +11.16%
02:51PM	Final Trades: NRG Energy, MP Materials, CareDx and Applovin (CNBC TV)
Feb-05-25 09:55AM	Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect? (Zacks)
Jan-29-25 09:40AM	Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-28-25 08:19AM	CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results (Insider Monkey)
Jan-24-25 08:35AM	Heres Why CareDx (CDNA) Traded Lower in Q4 (Insider Monkey)
Jan-15-25 03:50PM	Wells Fargo upgrades CareDx after a 30% pullback in stock (Investing.com)
Jan-14-25 03:43AM	Strength Seen in CareDx (CDNA): Can Its 6.1% Jump Turn into More Strength? (Zacks) -12.05%
Jan-13-25 07:00AM	CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results (Business Wire) +6.09%
09:35AM	Loading…
Jan-06-25 09:35AM	Implied Volatility Surging for CareDx (CDNA) Stock Options (Zacks)
Dec-18-24 07:05AM	CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) -7.86%
Dec-11-24 07:00AM	TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy (PR Newswire)
07:00AM	CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy (Business Wire)
Dec-03-24 09:40AM	Has CareDx (CDNA) Outpaced Other Medical Stocks This Year? (Zacks)
Nov-29-24 10:46AM	Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA) (Insider Monkey)
Nov-25-24 09:55AM	Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know (Zacks)
Nov-15-24 09:35AM	After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) (Zacks)
Nov-14-24 09:40AM	Are Medical Stocks Lagging CareDx (CDNA) This Year? (Zacks) -5.40%
Nov-12-24 07:05AM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
Nov-07-24 09:04AM	Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 (Insider Monkey)
Nov-05-24 01:03PM	Q3 2024 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
02:06AM	CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... (GuruFocus.com)
Nov-04-24 05:03PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance (Business Wire)
Oct-23-24 07:00AM	CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology (Business Wire)
Oct-21-24 07:00AM	CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting (Business Wire)
Oct-17-24 03:06PM	State Street Corp's Strategic Reduction in CareDx Inc Holdings (GuruFocus.com) -6.49%
Oct-16-24 08:17AM	CareDx Reports Strong Q3 2024 Revenue Growth (TipRanks)
Oct-15-24 06:00AM	CareDx Reports Preliminary Financial Results for Third Quarter 2024 (Business Wire) -15.84%
Oct-11-24 04:30PM	CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-09-24 03:35PM	CareDx Inc (CDNA) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Adjusted ... (GuruFocus.com) -12.42%
07:05AM	CareDx Appoints Jing Huang Chief Data and AI Officer (Business Wire)
Oct-08-24 04:05PM	CareDx to Host Investor Day on October 15, 2024 (Business Wire)
06:05AM	CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing (Business Wire)
Sep-13-24 08:35PM	CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:33PM	CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-12-24 07:01AM	CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer (Business Wire)
Aug-26-24 06:06AM	CareDx (CDNA) Surged Due to Positive Testing Volume Growth (Insider Monkey)
04:36AM	Here's Why Baron Discovery Fund Increased its Holdings in Veracyte (VCYT) (Insider Monkey)
Aug-16-24 02:10PM	CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing (Business Wire) +16.40%
Aug-09-24 09:15AM	CareDx, Inc. (CDNA) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-07-24 12:00PM	CareDx (CDNA) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Aug-06-24 03:58PM	CareDx, Inc (CDNA): Among the Best Organ Transplant and Diagnosis Stocks to Buy According to Hedge Funds? (Insider Monkey) +5.57%
Jul-31-24 08:00PM	Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key Metrics (Zacks) +6.56% +17.96%
06:05PM	CareDx (CDNA) Q2 Earnings and Revenues Beat Estimates (Zacks)
05:01PM	CareDx: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance (Business Wire)
Jul-16-24 07:05AM	CareDx to Report Second Quarter 2024 Financial Results (Business Wire) +15.06%
Jun-03-24 07:05AM	Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients (Business Wire)
May-30-24 07:05AM	AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress (Business Wire)
May-29-24 08:05AM	CareDx Reiterates Position that it Does Not Infringe the 544 Patent, Injunction Motion is Irrelevant (Business Wire) -16.69%
07:05AM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
May-16-24 04:05PM	Landmark Study Shows CareDx's HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies (Business Wire)
May-14-24 07:17AM	--Raymond James Downgrades CareDx to Market Perform From Outperform (MT Newswires)
May-13-24 10:12AM	Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating (MT Newswires)
May-10-24 02:26PM	CareDx Shares Rise After Q1 Results Beat Estimates (MT Newswires) +34.09%
02:21PM	CareDx Reports Mixed Q1 2024 Results; Raises Annual Revenue Guidance (GuruFocus.com)
11:46AM	CareDx, Inc (NASDAQ:CDNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 07:00PM	CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +8.64%
05:32PM	CareDx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports First Quarter 2024 Results (Business Wire)
May-07-24 09:15AM	CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
May-03-24 04:10PM	CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-29-24 04:05PM	CareDx to Report First Quarter 2024 Financial Results (Business Wire) +8.47% -5.37%
Apr-19-24 04:05PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-18-24 03:47AM	CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last? (Zacks)
Apr-16-24 04:02PM	CareDx Appoints John W. Hanna as its New President and Chief Executive Officer (Business Wire) +5.48%
Apr-09-24 07:00AM	CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-01-24 08:40AM	How CareDx (CDNA) Stock Stands Out in a Strong Industry (Zacks)
Mar-11-24 04:10PM	CareDx Appoints Bryan Riggsbee to Its Board of Directors (Business Wire)
Feb-29-24 10:43AM	CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.47%
06:59AM	Q4 2023 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 07:00PM	CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:28PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:57PM	CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023 (GuruFocus.com)
04:05PM	CareDx Announces Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-27-24 04:05PM	CareDx to Participate in the Raymond James & Associates 45th Annual Institutional Investors Conference (Business Wire) +6.39%
Feb-26-24 09:15AM	Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics (Zacks) +7.86%
Feb-21-24 04:05PM	CareDx to Report Fourth Quarter and Full Year 2023 Financial Results (Business Wire)

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COURNOYER CHRISTINE	Director	May 06 '25	Sale	14.13	16,700	235,929	37,045	May 08 04:31 PM
Novack Jeffrey Adam	Secretary and General Counsel	May 05 '25	Sale	14.70	2,688	39,514	121,350	May 07 04:38 PM
Christine M. Cournoyer	Director	May 06 '25	Proposed Sale	15.17	16,700	253,339		May 06 05:00 PM
Jeffrey Adam Novack	Officer	May 05 '25	Proposed Sale	15.00	2,688	40,320		May 05 04:39 PM
Maag Peter	Director	Apr 30 '25	Sale	17.23	13,281	228,796	316,743	May 02 04:49 PM
PETER MAAG	Director	Apr 30 '25	Proposed Sale	18.13	33,281	603,385		Apr 30 04:18 PM
Jain Abhishek	Chief Financial Officer	Apr 07 '25	Sale	17.72	265	4,696	337,418	Apr 09 04:31 PM
Novack Jeffrey Adam	Secretary and General Counsel	Apr 07 '25	Sale	17.72	924	16,373	126,911	Apr 09 04:30 PM
Bickerstaff George	Director	Mar 10 '25	Sale	18.36	20,000	367,102	103,027	Mar 12 04:30 PM
GEORGE W BICKERSTAFF	Director	Mar 10 '25	Proposed Sale	18.36	20,000	367,102		Mar 10 05:03 PM
Novack Jeffrey Adam	Secretary and General Counsel	Feb 04 '25	Sale	23.30	3,512	81,829	104,677	Feb 05 04:30 PM
Jeffrey Adam Novack	Officer	Feb 04 '25	Proposed Sale	23.32	3,512	81,900		Feb 04 04:18 PM
Novack Jeffrey Adam	Secretary and General Counsel	Dec 04 '24	Sale	26.00	1,917	49,842	110,237	Dec 06 04:32 PM
Jeffrey Adam Novack	Officer	Dec 04 '24	Proposed Sale	24.96	1,917	47,848		Dec 04 04:42 PM
Maag Peter	Director	Nov 26 '24	Option Exercise	12.24	5,000	61,200	335,024	Dec 03 08:54 PM
Maag Peter	Director	Nov 26 '24	Sale	25.00	5,000	125,000	330,024	Dec 03 08:54 PM
Novack Jeffrey Adam	Secretary and General Counsel	Nov 18 '24	Sale	21.77	5,534	120,477	113,377	Dec 03 04:31 PM
Novack Jeffrey Adam	Secretary and General Counsel	Nov 25 '24	Sale	24.00	1,223	29,352	112,154	Dec 03 04:31 PM
PETER MAAG	Director	Nov 26 '24	Proposed Sale	24.11	5,000	120,550		Nov 26 04:25 PM
JEFFREY NOVACK	Officer	Nov 25 '24	Proposed Sale	23.13	1,223	28,288		Nov 25 04:45 PM
JEFFREY NOVACK	Officer	Nov 18 '24	Proposed Sale	21.17	5,534	117,155		Nov 18 05:11 PM
Bickerstaff George	Director	Nov 01 '24	Option Exercise	5.74	7,481	42,962	123,027	Nov 05 04:42 PM
Johnson Alexander L	See Remarks	Aug 20 '24	Option Exercise	23.48	39,466	926,662	324,449	Aug 22 05:15 PM
Johnson Alexander L	See Remarks	Aug 21 '24	Option Exercise	23.48	21,557	506,158	306,540	Aug 22 05:15 PM
Johnson Alexander L	See Remarks	Aug 20 '24	Sale	33.17	39,466	1,309,087	284,983	Aug 22 05:15 PM
Johnson Alexander L	See Remarks	Aug 21 '24	Sale	32.58	21,557	702,327	284,983	Aug 22 05:15 PM
Maag Peter	Director	Aug 20 '24	Option Exercise	7.96	26,708	212,596	365,576	Aug 22 04:43 PM
Maag Peter	Director	Aug 20 '24	Sale	33.04	35,552	1,174,493	330,024	Aug 22 04:43 PM
Johnson Alexander L	See Remarks	Aug 19 '24	Sale	33.55	34,231	1,148,335	284,983	Aug 21 04:38 PM
Johnson Alexander L	Officer	Aug 20 '24	Proposed Sale	33.00	61,023	2,013,759		Aug 20 06:25 PM
Johnson Alexander L	Officer	Aug 19 '24	Proposed Sale	33.55	34,231	1,148,355		Aug 20 06:21 PM
Maag Peter	Director	Aug 20 '24	Proposed Sale	33.51	35,552	1,191,478		Aug 20 05:13 PM
Bickerstaff George	Director	May 14 '24	Option Exercise	10.00	5,255	52,550	104,976	May 16 04:38 PM

Dollar change -0.04
Percentage change -0.24	%

SPOK Spok Holdings Inc daily Stock Chart

Peers: VZ T TMUS USM INTC CSCO ADTN CMTL ERIC CALX

| Held by: VTI IWM VXF IWN DES VTWO FDLS DFAS DFAT VFMV

Index	RUT	P/E	21.31	EPS (ttm)	0.77	Insider Own	2.29%	Shs Outstand	20.56M	Perf Week	1.54%
Market Cap	339.45M	Forward P/E	20.89	EPS next Y	0.79	Insider Trans	-40.32%	Shs Float	20.10M	Perf Month	8.98%
Income	15.93M	PEG	-	EPS next Q	0.18	Inst Own	57.65%	Short Float	1.46%	Perf Quarter	1.66%
Sales	139.04M	P/S	2.44	EPS this Y	12.33%	Inst Trans	-3.80%	Short Ratio	1.92	Perf Half Y	3.58%
Book/sh	7.38	P/B	2.24	EPS next Y	-3.66%	ROA	7.59%	Short Interest	0.29M	Perf Year	13.17%
Cash/sh	0.97	P/C	17.08	EPS next 5Y	-	ROE	10.21%	52W Range	13.55 - 17.96	Perf YTD	2.80%
Dividend Est.	-	P/FCF	13.01	EPS past 5Y	-	ROI	10.14%	52W High	-8.13%	Beta	0.49
Dividend TTM	1.25 (7.58%)	Quick Ratio	1.24	Sales past 5Y	-2.93%	Gross Margin	59.51%	52W Low	21.77%	ATR (14)	0.55
Dividend Ex-Date	May 23, 2025	Current Ratio	1.24	EPS Y/Y TTM	-6.54%	Oper. Margin	14.98%	RSI (14)	59.34	Volatility	2.55% 3.88%
Employees	410	Debt/Eq	0.05	Sales Y/Y TTM	-1.22%	Profit Margin	11.45%	Recom	1.00	Target Price	20.00
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	21.38%	Payout	171.77%	Rel Volume	0.39	Prev Close	16.54
Sales Surprise	6.75%	EPS Surprise	38.89%	Sales Q/Q	3.97%	Earnings	Apr 30 AMC	Avg Volume	153.04K	Price	16.50
SMA20	5.95%	SMA50	3.86%	SMA200	4.84%	Trades		Volume	40,289	Change	-0.24%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-27-25	Upgrade	B. Riley Securities	Neutral → Buy	$15 → $20
Sep-26-24	Initiated	B. Riley Securities	Neutral	$15
Dec-19-22	Resumed	Lake Street	Buy	$15
Sep-23-22	Initiated	Lake Street	Buy	$14

May-01-25 03:19AM	Spok Holdings Inc (SPOK) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +13.18%
Apr-30-25 08:55PM	Spok Holdings, Inc. (SPOK) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:10PM	Spok Holdings (SPOK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:10PM	Spok: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Spok Reports First Quarter 2025 Results (Business Wire)
02:29PM	Loading…
Apr-23-25 02:29PM	Spok Sets Date to Report First Quarter 2025 Results (Business Wire)
07:45AM	AT&T (T) Q1 Earnings Miss Estimates (Zacks)
Apr-10-25 11:07AM	Gogo (GOGO) Moves 15.7% Higher: Will This Strength Last? (Zacks)
Mar-25-25 08:30AM	Spok Achieves Top Client Satisfaction Scores for Eighth Consecutive Year (Business Wire)
Mar-24-25 06:03PM	Spok Holdings (SPOK): Among Top Dividend Stocks that Pay More than the US Average Rental Yield (InsiderMonkey)
Feb-27-25 07:25AM	Q4 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
02:25AM	Spok Holdings Inc (SPOK) Q4 2024 Earnings Call Highlights: Strong Software Growth Amid Revenue ... (GuruFocus.com)
Feb-26-25 06:15PM	Spok Holdings (SPOK) Q4 Earnings and Revenues Miss Estimates (Zacks)
05:17PM	Spok: Q4 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
10:57AM	Loading…
Feb-25-25 10:57AM	Earnings To Watch: Spok Holdings Inc (SPOK) Reports Q4 2024 Result (GuruFocus.com)
Feb-19-25 04:00PM	Spok Sets Date to Report Fourth Quarter and Full Year 2024 Results (Business Wire)
Nov-01-24 07:01AM	Spok Holdings Inc (SPOK) Q3 2024 Earnings Call Highlights: Strong Software Bookings Amid ... (GuruFocus.com)
Oct-30-24 05:35PM	Spok: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Third Quarter 2024 Results (Business Wire)
Oct-29-24 09:16AM	Earnings To Watch: Spok Holdings Inc (SPOK) Reports Q3 2024 Result (GuruFocus.com)
Oct-24-24 09:15AM	Spok Customers Highlighted on U.S. News & World Reports Childrens Best Hospitals Honor Roll (Business Wire)
Oct-23-24 02:00PM	Spok Sets Date to Report Third Quarter 2024 Results (Business Wire)
Oct-22-24 09:15AM	14th Annual Spok Survey Offers Insights Into Evolving Healthcare Communications Challenges and Opportunities (Business Wire)
Aug-21-24 07:01PM	Insider Sale: COO Michael Wallace Sells 25,000 Shares of Spok Holdings Inc (SPOK) (GuruFocus.com)
Jul-25-24 12:00PM	Spok Holdings (SPOK) Q2 Earnings and Revenues Decline Y/Y (Zacks) -6.50%
09:28AM	Q2 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-24-24 04:48PM	Spok: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Second Quarter 2024 Results (Business Wire)
Jul-18-24 10:54AM	Spok Customers Recognized on U.S. News & World Report's Best Hospitals Honor Roll (Business Wire)
10:29AM	Loading…
Jul-17-24 10:29AM	Spok Sets Date to Report Second Quarter 2024 Results (Business Wire)
Jul-08-24 09:15AM	Spok Celebrates a Decade of Excellence and Innovation (Business Wire)
May-02-24 12:36PM	Spok Holdings, Inc. (NASDAQ:SPOK) Q1 2024 Earnings Call Transcript (Insider Monkey) -8.08%
08:10AM	Q1 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:40AM	Spok Holdings Inc (SPOK) Q1 2024 Earnings Call Transcript Highlights: A Strong Start with ... (GuruFocus.com)
May-01-24 10:55PM	SPOK Stock Earnings: Spok Holdings Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Spok Holdings Inc (SPOK) Reports Strong Q1 2024 Earnings, Surpassing Revenue Expectations (GuruFocus.com)
05:50PM	Spok: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports First Quarter 2024 Results (Business Wire)
Apr-24-24 09:00AM	Spok Sets Date to Report First Quarter 2024 Results (Business Wire)
Apr-02-24 09:15AM	Spok Achieves Top Client Satisfaction Scores for Seventh Consecutive Year (Business Wire)
Mar-30-24 05:00PM	Sub-$20 Superstars: 3 Stocks Ready to Double Your Money (InvestorPlace)
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-07-24 09:15AM	Spok to Showcase the Latest Advancements to Top-Rated Secure Healthcare Communication and Collaboration Platform at HIMSS24 (Business Wire)
Mar-06-24 10:00AM	Spok to Present at Sidoti Virtual Investor Conference (Business Wire)
Mar-04-24 11:29PM	Insider Sell: COO Michael Wallace Sells 40,000 Shares of Spok Holdings Inc (SPOK) (GuruFocus.com)
Feb-28-24 05:14PM	3 Underestimated Stocks With 900% Upside Potential (InvestorPlace)
02:27PM	The Dividend Promise: 3 Stocks Set to Deliver in March 2024 (InvestorPlace)
Feb-22-24 11:22AM	Spok Holdings, Inc. (NASDAQ:SPOK) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.25%
06:54AM	Q4 2023 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 05:25PM	Spok: Q4 Earnings Snapshot (Associated Press Finance)
04:45PM	Spok Holdings Inc (SPOK) Reports Revenue Growth and Record Software Bookings in 2023 (GuruFocus.com)
04:10PM	Spok Reports Fourth Quarter And Full Year 2023 Results (Business Wire)
Feb-17-24 02:00PM	Hidden Gems: 3 Stocks Under $20 With 5X Growth Potential by 2027 (InvestorPlace)
Feb-14-24 04:10PM	Spok Sets Date to Report Fourth Quarter and Full Year 2023 Results (Business Wire)
Jan-23-24 06:07PM	3 Small-Cap Stocks Ready to Rocket by 2025 (InvestorPlace)
Dec-25-23 02:53PM	From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune (InvestorPlace)
Dec-01-23 08:59AM	Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio (InvestorPlace)
Nov-16-23 04:05PM	Spok to Present and Host 1x1 Investor Meetings at the 35th Annual Piper Sandler & Co. Healthcare Conference (Business Wire)
Nov-07-23 05:04AM	Director Barbara Byrne Acquires 10,000 Shares of Spok Holdings Inc (GuruFocus.com)
Oct-28-23 01:57PM	Spok Holdings, Inc. (NASDAQ:SPOK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-25-23 06:06PM	Spok Holdings Inc (SPOK) Reports Improved Net Income and Adjusted EBITDA in Q3 2023 (GuruFocus.com)
05:30PM	Spok: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Third Quarter 2023 Results (Business Wire)
Oct-19-23 06:58PM	Spok Sets Date to Report Third Quarter 2023 Results (Business Wire)
Oct-11-23 09:15AM	13th Annual Spok Survey Reveals the State of Healthcare Communications in 2023 (Business Wire)
Aug-02-23 09:15AM	U.S. News and World Report Names Spok Customers to Best Hospitals Honor Roll (Business Wire)
Jul-27-23 10:42PM	Q2 2023 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents) +16.70% +10.71%
01:04PM	Why Shares of Spok Are Rising Thursday (Motley Fool)
Jul-26-23 05:22PM	Spok: Q2 Earnings Snapshot (AP Finance)
04:10PM	Spok Reports Second Quarter 2023 Results (Business Wire)
Jul-20-23 11:12AM	Spok Sets Date to Report Second Quarter 2023 Results (Business Wire)
Jun-13-23 09:00AM	Spok to Present and Host 1x1 Investor Meetings at the 13th Annual East Coast Virtual IDEAS Investor Conference on June 21st & 22nd (Business Wire)
May-22-23 09:00AM	Spok set to join Russell 3000® and Russell 2000® Index (Business Wire)
May-08-23 09:35AM	SPOK TO PRESENT AT THE INAUGURAL EF HUTTON GLOBAL CONFERENCE (GlobeNewswire)
May-03-23 06:08PM	Spok: Q1 Earnings Snapshot (AP Finance)
04:05PM	Spok Reports First Quarter 2023 Results (Business Wire)
Apr-27-23 12:00PM	Spok Sets Date to Report First Quarter 2023 Results (Business Wire)
Apr-14-23 08:54AM	10 Best Telecom Dividend Stocks To Buy for 2023 (Insider Monkey)
Apr-11-23 09:15AM	Spok to Demonstrate Top-Rated Secure Healthcare Communication and Collaboration Platform at HIMSS23 (Business Wire)
Apr-05-23 09:00AM	Spok Announces Update for May 2023 Investor Day (Business Wire)
Mar-02-23 04:10PM	Spok to Host Investor Day in May 2023 (Business Wire)
Feb-28-23 09:15AM	Spok Earns Top Client Satisfaction Scores for Sixth Consecutive Year (Business Wire)
Feb-22-23 04:10PM	Spok Reports Fourth Quarter and Full Year 2022 Results (Business Wire)
Feb-21-23 09:09AM	15 Highest Yielding Dividend Stocks You Can Buy (Insider Monkey)
Feb-16-23 12:25PM	Spok Sets Date to Report Fourth Quarter and Full Year 2022 Results (Business Wire)
Feb-07-23 09:15AM	Spok Announces ISO 13485:2016 Certification (Business Wire)
Jan-26-23 09:31AM	Spok to Participate in the Lytham Partners Investor Select Conference (Business Wire)
Oct-26-22 04:05PM	Spok Reports Third Quarter 2022 Results (Business Wire)
Oct-24-22 09:25AM	12th Annual Spok Survey Reveals the State of Healthcare Communications in 2022 (Business Wire)
Oct-20-22 04:05PM	Spok Sets Date to Report Third Quarter 2022 Results (Business Wire)
Aug-08-22 09:10AM	U.S. News and World Report Names Spok Customers to Best Hospitals Honor Roll (Business Wire)
Aug-01-22 09:00AM	Spok Announces Executive Promotions, Further Strengthening Management Team (Business Wire)
Jul-30-22 11:30AM	Spok Holdings (SPOK) Q2 2022 Earnings Call Transcript (Motley Fool)
Jul-27-22 04:05PM	Spok Reports Second Quarter 2022 Results (Business Wire)
Jul-21-22 04:05PM	Spok Sets Date to Report Second Quarter 2022 Results (Business Wire)
Apr-28-22 02:30PM	Spok Holdings (SPOK) Q1 2022 Earnings Call Transcript (Motley Fool) -9.27%
07:00AM	Spok Reports First Quarter 2022 Results (Business Wire)
Apr-25-22 04:05PM	Spok Sets Date to Report First Quarter 2022 Results (Business Wire)
09:25AM	Spok to Continue Support of United States Air & Space Force Through Partnership with Tyto Athene (Business Wire)

Spok Holdings, Inc. engages in the provision of communication solutions. It provides call center operations, clinical alerting and notifications, one-way and advanced two-way wireless messaging services, mobile communications and public safety solutions. The company was founded in 1965 and is headquartered in Plano, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WALLACE MICHAEL W	Chief Operating Officer	May 07 '25	Sale	16.53	6,000	99,167	61,175	May 08 04:30 PM
KELLY VINCENT D	President & CEO	May 06 '25	Sale	16.40	30,000	492,054	157,817	May 07 04:30 PM
WALLACE MICHAEL W	Officer	May 07 '25	Proposed Sale	16.55	6,000	99,300		May 07 03:12 PM
KELLY VINCENT D	Officer	May 06 '25	Proposed Sale	16.40	30,000	492,052		May 06 04:47 PM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Mar 13 '25	Sale	16.02	16,253	260,415	20,000	Mar 14 04:30 PM
Stein Todd J	Director	Mar 10 '25	Sale	16.58	73,652	1,220,819	608,154	Mar 12 04:30 PM
Stein Todd J	Director	Mar 11 '25	Sale	16.36	3,969	64,949	606,329	Mar 12 04:30 PM
Rice Calvin	Chief Financial Officer & CAO	Mar 07 '25	Option Exercise	16.85	13,006	219,151	33,460	Mar 07 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Mar 07 '25	Option Exercise	16.85	34,682	584,392	77,105	Mar 07 04:30 PM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Mar 07 '25	Option Exercise	16.85	10,838	182,620	37,243	Mar 07 04:30 PM
KELLY VINCENT D	President & CEO	Mar 07 '25	Option Exercise	16.85	57,803	973,981	204,366	Mar 07 04:30 PM
Woods-Keisling Sharon	Officer	Mar 06 '25	Proposed Sale	16.38	16,253	266,224		Mar 06 03:02 PM
Stein Todd J	Director	Mar 03 '25	Sale	16.75	60,182	1,007,958	642,033	Mar 05 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Mar 04 '25	Sale	16.53	10,000	165,331	42,423	Mar 05 04:30 PM
COURNOYER CHRISTINE	Director	Mar 04 '25	Sale	16.51	12,000	198,085	18,567	Mar 05 04:30 PM
Christine M. Cournoyer	Director	Mar 04 '25	Proposed Sale	16.50	12,000	198,060		Mar 04 05:28 PM
KELLY VINCENT D	President & CEO	Mar 03 '25	Sale	16.73	30,000	501,897	146,563	Mar 04 04:30 PM
WALLACE MICHAEL W	Officer	Mar 04 '25	Proposed Sale	16.59	10,000	165,900		Mar 04 12:53 PM
KELLY VINCENT D	Officer	Mar 03 '25	Proposed Sale	16.73	30,000	501,897		Mar 03 04:31 PM
Braeside Capital II, L.P.	Affiliate of Director	Mar 03 '25	Proposed Sale	16.54	72,000	1,190,880		Mar 03 04:02 PM
Braeside Capital, L.P.	Affiliate of Director	Mar 03 '25	Proposed Sale	16.54	95,000	1,571,300		Mar 03 04:00 PM
WALLACE MICHAEL W	Chief Operating Officer	Nov 19 '24	Sale	15.95	12,000	191,382	37,465	Nov 20 04:30 PM
WALLACE MICHAEL W	Officer	Nov 19 '24	Proposed Sale	16.20	12,000	194,400		Nov 19 12:00 PM
Stein Todd J	Director	Nov 13 '24	Sale	17.09	900	15,385	689,576	Nov 15 04:30 PM
KELLY VINCENT D	President & CEO	Nov 13 '24	Sale	16.88	50,000	843,935	151,645	Nov 14 04:30 PM
KELLY VINCENT D	Officer	Nov 13 '24	Proposed Sale	16.88	50,000	843,934		Nov 13 05:02 PM
Stein Todd J	Director	Nov 11 '24	Sale	17.07	11,500	196,275	690,887	Nov 13 04:30 PM
Stein Todd J	Director	Nov 12 '24	Sale	17.03	1,888	32,145	689,999	Nov 13 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Aug 20 '24	Sale	14.80	25,000	369,950	49,465	Aug 21 04:30 PM
WALLACE MICHAEL W	Director	Aug 20 '24	Proposed Sale	14.70	25,000	367,500		Aug 20 01:50 PM
KELLY VINCENT D	President & CEO	Aug 19 '24	Sale	14.83	45,000	667,215	201,645	Aug 19 05:19 PM
KELLY VINCENT D	Officer	Aug 19 '24	Proposed Sale	14.79	45,000	665,385		Aug 19 05:05 PM
Byrne Barbara Peterson	Director	May 10 '24	Sale	15.18	5,955	90,397	30,473	May 13 04:00 PM

CDNA

Caredx Inc

SPOK

Spok Holdings Inc

Upgrade your FINVIZ experience